Literature DB >> 23327249

The burden of influenza B: a structured literature review.

W Paul Glezen1, Jordana K Schmier, Carrie M Kuehn, Kellie J Ryan, John Oxford.   

Abstract

We reviewed the epidemiology, clinical characteristics, disease severity, and economic burden of influenza B as reported in the peer-reviewed published literature. We used MEDLINE to perform a systematic literature review of peer-reviewed, English-language literature published between 1995 and 2010. Widely variable frequency data were reported. Clinical presentation of influenza B was similar to that of influenza A, although we observed conflicting reports. Influenza B-specific data on hospitalization rates, length of stay, and economic outcomes were limited but demonstrated that the burden of influenza B can be significant. The medical literature demonstrates that influenza B can pose a significant burden to the global population. The comprehensiveness and quality of reporting on influenza B, however, could be substantially improved. Few articles described complications. Additional data regarding the incidence, clinical burden, and economic impact of influenza B would augment our understanding of the disease and assist in vaccine development.

Mesh:

Year:  2013        PMID: 23327249      PMCID: PMC3673513          DOI: 10.2105/AJPH.2012.301137

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  131 in total

1.  Update: influenza activity--United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-05-05       Impact factor: 17.586

2.  Update: Influenza activity--United States and worldwide, 2004-05 season.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-07-01       Impact factor: 17.586

3.  Epidemiological and virological assessment of influenza activity in Europe, during the 2006-2007 winter.

Authors:  J M S Arkema; A Meijer; T J Meerhoff; J Van Der Velden; W J Paget
Journal:  Euro Surveill       Date:  2008-08-21

4.  An outbreak of influenza B among workers on an oil rig.

Authors:  F Johnston; V Krause; N Miller; L Barclay
Journal:  Commun Dis Intell       Date:  1997-04-17

5.  Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.

Authors:  A S Monto; D M Fleming; D Henry; R de Groot; M Makela; T Klein; M Elliott; O N Keene; C Y Man
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

6.  Update: influenza activity--United States and Worldwide, 1995-96 season, and composition of the 1996-97 influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-04-26       Impact factor: 17.586

7.  Viral etiology and epidemiology of acute lower respiratory tract infections in Korean children.

Authors:  B Y Yun; M R Kim; J Y Park; E H Choi; H J Lee; C K Yun
Journal:  Pediatr Infect Dis J       Date:  1995-12       Impact factor: 2.129

8.  Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.

Authors:  M Zambon; J Hays; A Webster; R Newman; O Keene
Journal:  Arch Intern Med       Date:  2001-09-24

9.  Simultaneous multiple viral infections in childhood acute lower respiratory tract infections in southern Taiwan.

Authors:  J J Huang; T Y Huang; M Y Huang; B H Chen; K H Lin; J E Jeng; J R Wu; Z K Dai
Journal:  J Trop Pediatr       Date:  1998-10       Impact factor: 1.165

10.  Travel and the emergence of infectious diseases.

Authors:  M E Wilson
Journal:  Emerg Infect Dis       Date:  1995 Apr-Jun       Impact factor: 6.883

View more
  139 in total

1.  Quadrivalent influenza vaccine in the United States.

Authors:  Manika Suryadevara; Joseph B Domachowske
Journal:  Hum Vaccin Immunother       Date:  2013-11-14       Impact factor: 3.452

Review 2.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

3.  Influenza B in a temperate region of northern India 2010-2016: co-circulation of the two lineages with northern hemispherical seasonality.

Authors:  Parvaiz A Koul; Varsha Potdar; Masooma Showkat; Hyder Mir; M S Chadha
Journal:  Virusdisease       Date:  2018-09-26

4.  Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy.

Authors:  Andrea Orsi; Giuseppina Maria Elena Colomba; Fanny Pojero; Giuseppe Calamusa; Cristiano Alicino; Cecilia Trucchi; Paola Canepa; Filippo Ansaldi; Francesco Vitale; Fabio Tramuto
Journal:  Hum Vaccin Immunother       Date:  2017-08-03       Impact factor: 3.452

5.  Anomalous influenza seasonality in the United States and the emergence of novel influenza B viruses.

Authors:  Rebecca K Borchering; Christian E Gunning; Deven V Gokhale; K Bodie Weedop; Arash Saeidpour; Tobias S Brett; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

6.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

7.  Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.

Authors:  Weina Sun; Ericka Kirkpatrick; Megan Ermler; Raffael Nachbagauer; Felix Broecker; Florian Krammer; Peter Palese
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

8.  Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.

Authors:  Iván Martínez-Baz; Ana Navascués; Francisco Pozo; Judith Chamorro; Esther Albeniz; Itziar Casado; Gabriel Reina; Manuel García Cenoz; Carmen Ezpeleta; Jesús Castilla
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model.

Authors:  Philippe Noriel Q Pascua; Bindumadhav M Marathe; Peter Vogel; Richard J Webby; Elena A Govorkova
Journal:  J Antimicrob Chemother       Date:  2019-05-01       Impact factor: 5.790

10.  Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.

Authors:  Evelien Vanderlinden; Bram Vrancken; Jeroen Van Houdt; Vivek K Rajwanshi; Sarah Gillemot; Graciela Andrei; Philippe Lemey; Lieve Naesens
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.